UN: 700,000 AIDS Patients Get Drugs, Funds Short

The number of AIDS patients receiving life-extending drugs in poor countries has jumped to 700,000 from 440,000 six months ago, U.N. agencies said on Wednesday, but warned much more needed to be done. The figure only amounted to 12 percent of the estimated 5.8 million adults needing antiretroviral therapy (ARV) in developing and transitional countries, they said. Enormous barriers remained, including a $2-billion funding gap, to reaching a target of three million people by the end of 2005, according to the “Progress Report” on the U.N. initiative known as “Three by Five.” About 38 million people worldwide, including 25 million in sub-Saharan Africa, are living with HIV/AIDS. Compiled by the World Health Organization (WHO) and the Joint United Nations Program on HIV/AIDS (UNAIDS), which set the goal on World AIDS Day 2003, the report was being presented to the annual gathering of world and business leaders at the Swiss resort of Davos. “The progress in the second half of 2004 has been dramatic, reaching the December milestone of 700,000 people,” which the report said had been the end-2004 target. Patients receive drugs through national programs, aid agencies, the private sector, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the U.S. President’s Emergency Plan for AIDS relief, the World Bank and other partners. In Washington, the U.S. global AIDS coordinator Randall Tobias told reporters that 155,000 people in the 15 countries targeted under the U.S. bilateral plan are getting the drugs. But the high cost of ARV drugs, averaging at least $300 per person per year, remained a barrier, according to the U.N. agencies, which are seeking a price of $50-200 by end-2005. “The upward trend was driven especially by countries in sub-Saharan Africa, where the number of people receiving ARV therapy doubled,” the report said. Sub-Saharan Africa has 310,000 people on treatment, although overall coverage remains low at about 8 percent of sufferers. In East and South Asia, the number of people on treatment doubled to 100,000, with Thailand accounting for half. In Latin America and the Caribbean, access to ARV therapy continued to improve, with 275,000 or an estimated two-thirds of all people in need under treatment. Brazil is leading the way by providing it for its entire population, the report said. Three countries — South Africa, India and Nigeria — account for 41 percent of the overall “unmet need” of 5.1 million adults, according to the report.

The number of AIDS patients receiving life-extending drugs in poor countries has jumped to 700,000 from 440,000 six months ago, U.N. agencies said on Wednesday, but warned much more needed to be done. The figure only amounted to 12 percent of the estimated 5.8 million adults needing antiretroviral therapy (ARV) in developing and transitional countries, they said. Enormous barriers remained, including a $2-billion funding gap, to reaching a target of three million people by the end of 2005, according to the “Progress Report” on the U.N. initiative known as “Three by Five.” About 38 million people worldwide, including 25 million in sub-Saharan Africa, are living with HIV/AIDS. Compiled by the World Health Organization (WHO) and the Joint United Nations Program on HIV/AIDS (UNAIDS), which set the goal on World AIDS Day 2003, the report was being presented to the annual gathering of world and business leaders at the Swiss resort of Davos. “The progress in the second half of 2004 has been dramatic, reaching the December milestone of 700,000 people,” which the report said had been the end-2004 target. Patients receive drugs through national programs, aid agencies, the private sector, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the U.S. President’s Emergency Plan for AIDS relief, the World Bank and other partners. In Washington, the U.S. global AIDS coordinator Randall Tobias told reporters that 155,000 people in the 15 countries targeted under the U.S. bilateral plan are getting the drugs. But the high cost of ARV drugs, averaging at least $300 per person per year, remained a barrier, according to the U.N. agencies, which are seeking a price of $50-200 by end-2005. “The upward trend was driven especially by countries in sub-Saharan Africa, where the number of people receiving ARV therapy doubled,” the report said. Sub-Saharan Africa has 310,000 people on treatment, although overall coverage remains low at about 8 percent of sufferers. In East and South Asia, the number of people on treatment doubled to 100,000, with Thailand accounting for half. In Latin America and the Caribbean, access to ARV therapy continued to improve, with 275,000 or an estimated two-thirds of all people in need under treatment. Brazil is leading the way by providing it for its entire population, the report said. Three countries — South Africa, India and Nigeria — account for 41 percent of the overall “unmet need” of 5.1 million adults, according to the report. (Source: United Nations, Reuters Health, January 2005)